News

Zoplar Secures $3.4 Million in Series A Led by Blume Ventures

Zoplar, a Gurugram-based platform simplifying medical equipment procurement for small and medium-sized hospitals, has raised $3.4 million in a Series A funding round. Blume Ventures spearheaded the round, with support from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX.

This fresh capital brings Zoplar’s total funding to $5.1 million, following earlier investments from Titan Capital, Stride Ventures, and Panthera Peak.

Strengthening Supply Chain and Services

Zoplar plans to channel the new funds into critical operational upgrades. The company aims to:

  • Focus on backward integration within its supply chain, ensuring seamless coordination with suppliers and manufacturers.
  • Build a service engineering team dedicated to offering high-quality after-sales support for its clients.

By prioritizing these areas, Zoplar hopes to solidify its position as a trusted partner for medical equipment procurement.

medical equipment procurement

Tackling Pain Points in Healthcare Procurement

Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar addresses key challenges faced by MSME (micro, small, and medium enterprises) hospitals. These include:

  • Price Transparency: Helping hospitals identify cost-effective medical equipment without compromising quality.
  • Vendor Management: Simplifying the process of managing multiple suppliers by offering a one-stop solution.
  • After-Sales Service: Ensuring reliable support through a dedicated engineering team.
  • Financing Options: Facilitating access to financing solutions for cash-strapped healthcare providers.

This full-stack approach has made Zoplar a game-changer in the medical procurement space.

Market Traction and Repeat Customers

In just three years, Zoplar has partnered with around 300 hospitals, including major nephrology chains such as DCDC. Its efforts are paying off, as evidenced by a 40% repeat customer rate—an indicator of trust and satisfaction within the medical community.

The demand for affordable, high-quality medical equipment in India’s healthcare sector is growing rapidly, particularly among smaller hospitals that lack the resources of larger institutions. Zoplar’s tailored solutions aim to bridge this gap.

Investors Bet on Zoplar’s Vision

Blume Ventures and other backers see significant potential in Zoplar’s ability to address inefficiencies in healthcare procurement. By providing a streamlined, tech-driven solution, the platform is well-positioned to capture a sizable share of a fragmented and underserved market.

Zoplar’s journey has only just begun, but with fresh funding and a clear focus on operational excellence, it’s poised to make a lasting impact on India’s healthcare ecosystem.

Comments

Your email address will not be published. Required fields are marked *